ARTICLE | Distillery Therapeutics
Peptide-based SARS-CoV-2 3CLpro inhibitor identified for COVID-19
October 27, 2020 8:03 PM UTC
DISEASE CATEGORY: Infectious disease
INDICATION: Coronavirus...
DISEASE CATEGORY: Infectious disease
INDICATION: Coronavirus...